Activity of Simulated Human Dosage Regimens of Meropenem and Vaborbactam Against Carbapenem-resistantEnterobacteriaceaein an in Vitro Hollow Fiber Model
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01969-17
Full Text
Open PDFAbstract
Available in full text
Date
November 13, 2017
Authors
Publisher
American Society for Microbiology